Cardiac gene therapy: Pumping up the heart
- 1 January 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (1) , 2-3
- https://doi.org/10.1038/sj.gt.3301910
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene deliveryNature Medicine, 2002
- Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failureThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Mixed signals in heart failure: cancer rulesJournal of Clinical Investigation, 2002
- Restoration of Deficient Membrane Proteins in the Cardiomyopathic Hamster by In Vivo Cardiac Gene TransferCirculation, 2002
- Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca 2+ -ATPase in a Rat Model of Heart FailureCirculation, 2001
- Anti–Tumor Necrosis Factor-α Antibody Limits Heart Failure in a Transgenic ModelCirculation, 2001
- Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban AblationPublished by Elsevier ,2001
- Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamstersAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failureProceedings of the National Academy of Sciences, 2000
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999